Okada J, Kosakai N, Oguri T
Jpn J Antibiot. 1977 Jul;30(7):505-10.
The antimicrobial activities of ampicillin (ABPC) and dicloxacillin (MDIPC) alone were tested in 100 strains of B. fragilis isolated from clinical specimens, and combined activity of ABPC and MDIPC was investigated employing a chequer board titration method (Box method) with agar plates and liquid media. The following results were obtained. 1. Of the 100 strains tested, approximately 33% were shown to have MICs of ABPC greater than 100 mcg/ml, whereas 92% of strains were greater than 100 mcg/ml to MDIPC. 2. In the combination, antimicrobial activities were demonstrated additive or synergistic action in almost strains tested. 3. A combined effect of these drugs was proved by agar dilution method for the strains, for which the same effect was shown by the tube dilution method. 4. For ABPC-resistant strains, no increase in antibacterial activity of these drugs by combination was demonstrated.
对从临床标本中分离出的100株脆弱拟杆菌菌株单独测试了氨苄西林(ABPC)和双氯西林(MDIPC)的抗菌活性,并采用琼脂平板和液体培养基的棋盘滴定法(Box法)研究了ABPC和MDIPC的联合活性。获得了以下结果。1. 在测试的100株菌株中,约33%的菌株对ABPC的最低抑菌浓度(MIC)大于100 mcg/ml,而92%的菌株对MDIPC的MIC大于100 mcg/ml。2. 在联合使用中,几乎所有测试菌株都表现出抗菌活性的相加或协同作用。3. 通过琼脂稀释法对这些菌株证明了这些药物的联合效果,管稀释法也显示出相同的效果。4. 对于耐ABPC的菌株,未证明联合使用这些药物会增加抗菌活性。